VGN-R08b

N/A

Report date: 2026/05/25 20:02:40

Base Information

Drug NameVGN-R08b
Drug Alias NameVGN-R08b
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionBeta-glucocerebrosidase replacements
TargetsBeta-glucocerebrosidase
Therapy Area/IndicationsGaucher's disease type IIIGaucher's disease type IIGaucher's disease type I +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Vitalgen BioPharma Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesTianze Yuntai (Shenzhen) Biopharmaceutical Co LtdShanghai Vitalgen BioPharma Co Ltd
Inactive CompaniesN/A
Active IndicationsGaucher's disease type IIIGaucher's disease type IIGaucher's disease type I +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A